Bi-allelic GAD1 variants cause a neonatal onset syndromic developmental and epileptic encephalopathy
Open Access
- 13 April 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Brain
- Vol. 143 (5), 1447-1461
- https://doi.org/10.1093/brain/awaa085
Abstract
Developmental and epileptic encephalopathies are a heterogeneous group of early-onset epilepsy syndromes dramatically impairing neurodevelopment. Modern genomic technologies have revealed a number of monogenic origins and opened the door to therapeutic hopes. Here we describe a new syndromic developmental and epileptic encephalopathy caused by bi-allelic loss-of-function variants in GAD1, as presented by 11 patients from six independent consanguineous families. Seizure onset occurred in the first 2 months of life in all patients. All 10 patients, from whom early disease history was available, presented with seizure onset in the first month of life, mainly consisting of epileptic spasms or myoclonic seizures. Early EEG showed suppression-burst or pattern of burst attenuation or hypsarrhythmia if only recorded in the post-neonatal period. Eight patients had joint contractures and/or pes equinovarus. Seven patients presented a cleft palate and two also had an omphalocele, reproducing the phenotype of the knockout Gad1−/− mouse model. Four patients died before 4 years of age. GAD1 encodes the glutamate decarboxylase enzyme GAD67, a critical actor of the γ-aminobutyric acid (GABA) metabolism as it catalyses the decarboxylation of glutamic acid to form GABA. Our findings evoke a novel syndrome related to GAD67 deficiency, characterized by the unique association of developmental and epileptic encephalopathies, cleft palate, joint contractures and/or omphalocele.Funding Information
- Swedish Research Council
- Swedish Society of Medicine
- European Union’s Seventh Framework Programme (608473)
- European Science Foundation
- BOF-University of Antwerp (FFB180053)
- FWO-FKM (1861419N)
- European Research Council
- ERC
- Starting Grant TREAT Cilia (716344)
- Yale Center for Mendelian Genomics
- GSP Coordinating Center
- NHGRI
- NHLBI (UM1HG006504, U24 HG008956)
- National Institutes of Health
- le plan Technologies de la Santé par le Gouvernement du Grand-Duché de Luxembourg
- Luxembourg Centre for Systems Biomedicine
- University of Luxembourg
This publication has 33 references indexed in Scilit:
- De novo mutations in epileptic encephalopathiesNature, 2013
- The physiological roles of vesicular GABA transporter during embryonic development: a study using knockout miceMolecular Brain, 2010
- Protein structure analysis of mutations causing inheritable diseases. An e-Science approach with life scientist friendly interfacesBMC Bioinformatics, 2010
- Cleft Palate Is Caused by CNS Dysfunction in Gad1 and Viaat Knockout MicePLOS ONE, 2010
- Experimental induction of palate shelf elevation in glutamate decarboxylase 67‐deficient mice with cleft palate due to vertically oriented palatal shelfBirth Defects Research Part A: Clinical and Molecular Teratology, 2007
- Systematic study of association of four GABAergic genes: Glutamic acid decarboxylase 1 gene, glutamic acid decarboxylase 2 gene, GABAB receptor 1 gene and GABAA receptor subunit β2 gene, with schizophrenia using a universal DNA microarraySchizophrenia Research, 2007
- Definition, classification, and the clinicianDevelopmental Medicine and Child Neurology, 2007
- Association between nonsyndromic cleft lip with or without cleft palate and the glutamic acid decarboxylase 67 gene in the Japanese populationAmerican Journal of Medical Genetics Part A, 2003
- Targeting of the 67-kDa Isoform of Glutamic Acid Decarboxylase to Intracellular Organelles Is Mediated by Its Interaction with the NH2-terminal Region of the 65-kDa Isoform of Glutamic Acid DecarboxylaseOnline Journal of Public Health Informatics, 1995
- Genetic Aspects of Cerebral PalsyDevelopmental Medicine and Child Neurology, 1992